A brominated
thiazolyl benzenesulfonamide (BTB) derivative is conjugated
with the cell-penetrating peptide octaarginine (R8) in an effort to
construct innovative antibacterial products. The noncovalent complex
of BTB and R8 is characterized by Fourier transform infrared (FTIR)
spectroscopy, which indicates hydrogen bonding between the two constituents.
Attachment of the peptide moiety renders aqueous solubility to the
hydrophobic benzenesulfonamide drug and bestows bactericidal activity.
Confocal imaging in conjunction with dye probes shows successful clearance
of intracellular Staphylococcus aureus bacteria by the BTB–R8 complex. Scanning electron micrographs
and studies with a set of fluorescent dyes suggest active disruption
of the bacterial cell membrane by the BTB–R8 complex. In contrast,
the complex of BTB with octalysine (K8) fails to cause membrane damage
and displays a modest antibacterial effect. A complex of BTB with
the water-soluble hydrophilic polymer poly(vinylpyrrolidone) (PVP)
does not display any antibacterial effect, indicating the distinctive
role of the cell-penetrating peptide (CPP) R8 in the cognate complex.
The leakage of the encapsulated dye from giant unilamellar vesicles
upon interaction with the BTB–R8 complex further highlights
the membrane activity of the complex, which cannot be accomplished
by bare sulfonamide alone. This work broadens the scope of use of
CPPs with respect to eliciting antibacterial activity and potentially
expands the limited arsenal of membrane-targeting antibiotics.